C. M. Reyes

Long-acting somatostatin analog therapy of acromegaly: a meta-analysis.

D. Rabinowitz, A. J. van der Lely, P. Freda, 2005, The Journal of clinical endocrinology and metabolism.

Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy.

S. Wardlaw, P. Freda, C. M. Reyes, 2003, The Journal of clinical endocrinology and metabolism.

Basal and Glucose-Suppressed GH Levels Less Than 1 μg/L in Newly Diagnosed Acromegaly

J. Bruce, P. Freda, C. M. Reyes, 2004, Pituitary.

Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly.

P. Freda, C. M. Reyes, S. Jehle, 2005, The Journal of clinical endocrinology and metabolism.

Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.

P. Freda, K. Post, C. M. Reyes, 2004, The Journal of clinical endocrinology and metabolism.

Cabergoline Therapy of Growth Hormone & Growth Hormone/Prolactin Secreting Pituitary Tumors

A. Khandji, P. Freda, K. Post, 2004, Pituitary.